Switzerland-headquartered BC Platforms (BCP), a global leader in healthcare data management and analytics, has announced an expanded partnership with Thailand’s Bumrungrad International Hospital, one of the largest private hospitals in Southeast Asia and a world leader in healthcare delivery and pioneering clinical research.
The extended partnership, first formed in February 2019, builds on clinical sample management functionalities and existing automated workflows for genotype-based wellness reporting and neonatal screening supported by BCP solutions. Bumrungrad will be able to utilize BCP’s Personalized Medicine Platform, to implement end-to-end clinical workflows for germline and somatic tumor testing, enabling data-driven personalized care for patients.
Additionally, BCP will provide its Discovery and Research Platform, for curating and analyzing clinical and omics data in a secure format. This will enhance translational research capabilities at Bumrungrad and boost research collaborations. Bumrungrad will also become a BCP data partner and will contribute with diverse data samples for research.
Founded in 1980, Bumrungrad International Hospital has been a global pioneer in providing world-class healthcare services and international patient support for nearly four decades. Located in the heart of Bangkok, Bumrungrad is an internationally accredited, multi-specialty hospital listed on the Stock Exchange of Thailand since 1989. Bumrungrad International Hospital cares for over 1.1 million patients from more than 190 countries annually.
(Source: BC Platforms)
